Skip to main content
. 2021 Nov 12;11:796839. doi: 10.3389/fonc.2021.796839

Figure 2.

Figure 2

The clinical significance of FBI-1/HIF-1α axis in HCC. (A–C) The correlation between FBI-1 with HIF-1α-pathway-related factors. (D–F) The correlation between FBI-1 with advanced HCC patients who received sorafenib. (G–I) The correlation between HIF-1α with advanced HCC patients who received sorafenib. *p < 0.05.